B. Oyan Et Al. , "Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
Oyan, B. Et Al. 2018. Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15 .
Oyan, B., Sonmez, Ö., Yazar, A., & Teomet, M., (2018). Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.
Oyan, BAŞAK Et Al. "Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
Oyan, BAŞAK O. Et Al. "Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
Oyan, B. Et Al. (2018) . "Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.
@article{article, author={BAŞAK OYAN ULUÇ Et Al. }, title={Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2018}